NURS 7430 - Quiz 4 Questions With
Correct Answers
Which ||regimen ||is ||considered ||appropriate ||therapy ||for ||treating ||infection ||with ||Helicobacter
||pylori ||associated ||ulcers? ||- ||CORRECT ||ANSWER✔✔-Proton ||pump ||inhibitor, ||clarithromycin ||
500 ||mg ||and ||metronidazole ||500 ||mg ||all ||twice ||daily ||for ||14 ||days
The ||MOST ||effective ||medication ||class ||for ||the ||treatment ||of ||Barrett's ||esophagus ||is: ||- ||
CORRECT ||ANSWER✔✔-Proton ||Pump ||inhibitors
True ||of ||False?
All ||of ||the ||currently ||FDA ||approved ||medications ||for ||obesity ||management ||are ||
contraindicated ||in ||pregnancy. ||- ||CORRECT ||ANSWER✔✔-True
Which ||class ||of ||anti-emetic ||medication ||has ||black ||box ||warnings ||on ||both ||medications ||used
||for ||nausea ||and ||vomiting ||treatment? ||- ||CORRECT ||ANSWER✔✔-phenothiazines ||(dopamine ||
antagonists)
Which ||drug's ||therapeutic ||effect ||is ||that ||it ||inhibits ||peristalsis? ||- ||CORRECT ||ANSWER✔✔-
Loperamide
Which ||H2 ||antagonist ||is ||known ||to ||interfere ||with ||drugs ||metabolized ||by ||the ||CYP-450 ||
system? ||- ||CORRECT ||ANSWER✔✔-cimetidine ||(Tagamet)
Cimetidine, ||famotidine ||and ||nizatidine ||belong ||to ||the ||class ||of ||medication ||which ||is ||
effective ||in ||treating ||ulcers ||and ||gastritis ||by ||which ||of ||the ||following ||mechanisms ||of ||action?
||- ||CORRECT ||ANSWER✔✔-This ||class ||of ||drug ||binds ||with ||H2 ||receptors ||which ||renders ||
histamine, ||a ||stimulus ||for ||acid ||production ||physiologically ||inactive.
, Which ||pharmacologic ||agent ||has ||the ||potential ||to ||cause ||increased ||biliary ||tree ||pressure? ||-
||CORRECT ||ANSWER✔✔-morphine
Which ||best ||describes ||the ||role ||of ||misoprostol ||(Cytotec) ||in ||preventing ||peptic ||ulcers ||
(PUD)? ||- ||CORRECT ||ANSWER✔✔-It ||is ||a ||synthetic ||prostaglandin ||with ||gastroprotective ||
effects ||when ||used ||with ||NSAIDs
Chronic ||use ||of ||antacid ||medication, ||such ||as ||proton ||pump ||inhibitors, ||in ||a ||person ||taking ||
aspirin ||for ||inhibition ||of ||platelet ||aggregation ||would ||have ||what ||effect ||on ||the ||absorption ||
of ||aspirin ||from ||the ||stomach? ||- ||CORRECT ||ANSWER✔✔-It ||would ||decrease ||the ||absorption
What ||immunization ||is ||recommended ||for ||healthy ||adults ||65 ||and ||over? ||The ||healthy ||
patient ||may ||receive ||this ||immunization ||earlier ||but ||it ||is ||recommended ||at ||and ||above ||65 ||
y/o. ||- ||CORRECT ||ANSWER✔✔-Pneumococcal
Antibody ||concentrations ||and ||responses ||to ||individual ||antigens ||vary. ||Typically, ||how ||long ||
does ||it ||take ||for ||a ||protective ||level ||of ||antibodies ||to ||develop ||in ||healthy ||adults? ||- ||
CORRECT ||ANSWER✔✔-Two ||to ||Three ||weeks.
(3) ||strategies ||employed ||in ||organ ||and ||tissue ||transplants ||are: ||- ||CORRECT ||ANSWER✔✔-- ||
Maintenance ||immunosuppressant ||therapy ||using ||less ||potent ||drugs ||to ||provide ||long ||term ||
protection.
- ||Induction ||therapy, ||powerfully ||suppress ||the ||immune ||system ||at ||the ||time ||of ||transplant ||
through ||the ||use ||of ||polyclonal ||or ||monoclonal ||antibodies.
- ||Use ||of ||multiple ||immunosuppressants ||at ||lower ||dosages ||to ||maintain ||adequate ||
immunosuppression ||while ||minimizing ||adverse ||effects.
Correct Answers
Which ||regimen ||is ||considered ||appropriate ||therapy ||for ||treating ||infection ||with ||Helicobacter
||pylori ||associated ||ulcers? ||- ||CORRECT ||ANSWER✔✔-Proton ||pump ||inhibitor, ||clarithromycin ||
500 ||mg ||and ||metronidazole ||500 ||mg ||all ||twice ||daily ||for ||14 ||days
The ||MOST ||effective ||medication ||class ||for ||the ||treatment ||of ||Barrett's ||esophagus ||is: ||- ||
CORRECT ||ANSWER✔✔-Proton ||Pump ||inhibitors
True ||of ||False?
All ||of ||the ||currently ||FDA ||approved ||medications ||for ||obesity ||management ||are ||
contraindicated ||in ||pregnancy. ||- ||CORRECT ||ANSWER✔✔-True
Which ||class ||of ||anti-emetic ||medication ||has ||black ||box ||warnings ||on ||both ||medications ||used
||for ||nausea ||and ||vomiting ||treatment? ||- ||CORRECT ||ANSWER✔✔-phenothiazines ||(dopamine ||
antagonists)
Which ||drug's ||therapeutic ||effect ||is ||that ||it ||inhibits ||peristalsis? ||- ||CORRECT ||ANSWER✔✔-
Loperamide
Which ||H2 ||antagonist ||is ||known ||to ||interfere ||with ||drugs ||metabolized ||by ||the ||CYP-450 ||
system? ||- ||CORRECT ||ANSWER✔✔-cimetidine ||(Tagamet)
Cimetidine, ||famotidine ||and ||nizatidine ||belong ||to ||the ||class ||of ||medication ||which ||is ||
effective ||in ||treating ||ulcers ||and ||gastritis ||by ||which ||of ||the ||following ||mechanisms ||of ||action?
||- ||CORRECT ||ANSWER✔✔-This ||class ||of ||drug ||binds ||with ||H2 ||receptors ||which ||renders ||
histamine, ||a ||stimulus ||for ||acid ||production ||physiologically ||inactive.
, Which ||pharmacologic ||agent ||has ||the ||potential ||to ||cause ||increased ||biliary ||tree ||pressure? ||-
||CORRECT ||ANSWER✔✔-morphine
Which ||best ||describes ||the ||role ||of ||misoprostol ||(Cytotec) ||in ||preventing ||peptic ||ulcers ||
(PUD)? ||- ||CORRECT ||ANSWER✔✔-It ||is ||a ||synthetic ||prostaglandin ||with ||gastroprotective ||
effects ||when ||used ||with ||NSAIDs
Chronic ||use ||of ||antacid ||medication, ||such ||as ||proton ||pump ||inhibitors, ||in ||a ||person ||taking ||
aspirin ||for ||inhibition ||of ||platelet ||aggregation ||would ||have ||what ||effect ||on ||the ||absorption ||
of ||aspirin ||from ||the ||stomach? ||- ||CORRECT ||ANSWER✔✔-It ||would ||decrease ||the ||absorption
What ||immunization ||is ||recommended ||for ||healthy ||adults ||65 ||and ||over? ||The ||healthy ||
patient ||may ||receive ||this ||immunization ||earlier ||but ||it ||is ||recommended ||at ||and ||above ||65 ||
y/o. ||- ||CORRECT ||ANSWER✔✔-Pneumococcal
Antibody ||concentrations ||and ||responses ||to ||individual ||antigens ||vary. ||Typically, ||how ||long ||
does ||it ||take ||for ||a ||protective ||level ||of ||antibodies ||to ||develop ||in ||healthy ||adults? ||- ||
CORRECT ||ANSWER✔✔-Two ||to ||Three ||weeks.
(3) ||strategies ||employed ||in ||organ ||and ||tissue ||transplants ||are: ||- ||CORRECT ||ANSWER✔✔-- ||
Maintenance ||immunosuppressant ||therapy ||using ||less ||potent ||drugs ||to ||provide ||long ||term ||
protection.
- ||Induction ||therapy, ||powerfully ||suppress ||the ||immune ||system ||at ||the ||time ||of ||transplant ||
through ||the ||use ||of ||polyclonal ||or ||monoclonal ||antibodies.
- ||Use ||of ||multiple ||immunosuppressants ||at ||lower ||dosages ||to ||maintain ||adequate ||
immunosuppression ||while ||minimizing ||adverse ||effects.
